Swift Biosciences is a fast-moving company focused on developing enabling technologies and products for genomics and personalized medicine. Our technologies provide customers with powerful new methods to examine disease-related genes. Our products are designed to help customers analyze samples faster, easier and with greater sensitivity and accuracy, while being compatible with existing instrumentation.

 

Swift's executive team has a strong track record of creating, marketing and selling products that are well regarded by the industry and customers alike. The company was created with the support of experienced life science investors and opened its doors in February 2010. Our multiple innovation platforms have been developed "in house" by our growing team of talented scientists and are covered by multiple patent applications.